Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris A Hadaschik

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
Brachytherapy|May 1, 2012
High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literaturePaul L Nguyen, Phillip M Devlin, Clair J Beard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2024
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [<sup>68</sup>Ga]Ga-/[<sup>18</sup>F]F-PSMA-11/-1007, [<sup>68</sup>Ga]Ga-FAPI-46 and 2-[<sup>18</sup>F]FDG PET/CT: a pilot studyKim M Pabst, Riccardo Mei, Katharina Lückerath, et al.
The Journal of Urology|April 24, 2013
Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancerTimur H Kuru, Matthias C Roethke, Jonas Seidenader, et al.
European Urology Open Science|February 1, 2024
Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS StudyBirte Valentin, Christian Arsov, Tim Ullrich, et al.
BJU International|November 24, 2019
External validation of novel magnetic resonance imaging-based models for prostate cancer predictionLukas Püllen, Jan P Radtke, Manuel Wiesenfarth, et al.
Urology|February 5, 2013
Pediatric case report on magnetic resonance imaging/transrectal ultrasound-fusion biopsy of rhabdomyosarcoma of the bladder/prostate: a new tool to reduce therapy-associated morbidity?Timur H Kuru, Matthias C Roethke, Joanne Nyarangi-Dix, et al.
European Urology Focus|September 11, 2020
Retroperitoneal Versus Transperitoneal Robotic Partial Nephrectomy: A Multicenter Matched-pair AnalysisNina N Harke, Christopher Darr, Jan Philipp Radtke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2014
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancerAli Afshar-Oromieh, Eleni Avtzi, Frederik L Giesel, et al.
Journal of Endourology|July 9, 2015
The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a StandardJan Philipp Radtke, Boris A Hadaschik, Maya B Wolf, et al.
The Journal of Urology|August 1, 2014
Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidanceJan P Radtke, Timur H Kuru, Silvan Boxler, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Brachytherapy|May 1, 2012
High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literaturePaul L Nguyen, Phillip M Devlin, Clair J Beard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2024
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [<sup>68</sup>Ga]Ga-/[<sup>18</sup>F]F-PSMA-11/-1007, [<sup>68</sup>Ga]Ga-FAPI-46 and 2-[<sup>18</sup>F]FDG PET/CT: a pilot studyKim M Pabst, Riccardo Mei, Katharina Lückerath, et al.
The Journal of Urology|April 24, 2013
Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancerTimur H Kuru, Matthias C Roethke, Jonas Seidenader, et al.
European Urology Open Science|February 1, 2024
Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS StudyBirte Valentin, Christian Arsov, Tim Ullrich, et al.
BJU International|November 24, 2019
External validation of novel magnetic resonance imaging-based models for prostate cancer predictionLukas Püllen, Jan P Radtke, Manuel Wiesenfarth, et al.
Urology|February 5, 2013
Pediatric case report on magnetic resonance imaging/transrectal ultrasound-fusion biopsy of rhabdomyosarcoma of the bladder/prostate: a new tool to reduce therapy-associated morbidity?Timur H Kuru, Matthias C Roethke, Joanne Nyarangi-Dix, et al.
European Urology Focus|September 11, 2020
Retroperitoneal Versus Transperitoneal Robotic Partial Nephrectomy: A Multicenter Matched-pair AnalysisNina N Harke, Christopher Darr, Jan Philipp Radtke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2014
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancerAli Afshar-Oromieh, Eleni Avtzi, Frederik L Giesel, et al.
Journal of Endourology|July 9, 2015
The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a StandardJan Philipp Radtke, Boris A Hadaschik, Maya B Wolf, et al.
The Journal of Urology|August 1, 2014
Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidanceJan P Radtke, Timur H Kuru, Silvan Boxler, et al.
Pageof 13